Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 28 2025
0mins
Should l Buy ?
Source: SeekingAlpha
Enzo Biochem Delisting Announcement: Enzo Biochem plans to voluntarily delist its common stock from the NYSE and transition to the OTCQX Best Market, with the delisting expected to take effect around April 17, 2025.
Market Reaction: Following the announcement, ENZ shares experienced a significant decline of over 19% in post-market trading on Friday.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
